- Home
- OTLK vs FAT Comparison
OTLK vs FAT Comparison
Compare OTLK & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- FAT
- Stock Information
- Founded
- OTLK 2010
- FAT 2017
- Country
- OTLK United States
- FAT United States
- Employees
- OTLK N/A
- FAT N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- FAT Restaurants
- Sector
- OTLK Health Care
- FAT Consumer Discretionary
- Exchange
- OTLK Nasdaq
- FAT Nasdaq
- Market Cap
- OTLK 48.3M
- FAT 45.6M
- IPO Year
- OTLK 2016
- FAT 2017
- Fundamental
- Price
- OTLK $1.71
- FAT $2.35
- Analyst Decision
- OTLK Strong Buy
- FAT Strong Buy
- Analyst Count
- OTLK 5
- FAT 1
- Target Price
- OTLK $9.60
- FAT $10.00
- AVG Volume (30 Days)
- OTLK 823.9K
- FAT 78.3K
- Earning Date
- OTLK 08-13-2025
- FAT 07-30-2025
- Dividend Yield
- OTLK N/A
- FAT 11.97%
- EPS Growth
- OTLK N/A
- FAT N/A
- EPS
- OTLK 0.83
- FAT N/A
- Revenue
- OTLK N/A
- FAT $582,704,000.00
- Revenue This Year
- OTLK N/A
- FAT N/A
- Revenue Next Year
- OTLK $379.84
- FAT $8.68
- P/E Ratio
- OTLK $2.06
- FAT N/A
- Revenue Growth
- OTLK N/A
- FAT 10.63
- 52 Week Low
- OTLK $0.87
- FAT $2.01
- 52 Week High
- OTLK $9.25
- FAT $4.10
- Technical
- Relative Strength Index (RSI)
- OTLK 46.49
- FAT 50.54
- Support Level
- OTLK $1.65
- FAT $2.42
- Resistance Level
- OTLK $1.97
- FAT $2.70
- Average True Range (ATR)
- OTLK 0.12
- FAT 0.21
- MACD
- OTLK -0.03
- FAT 0.02
- Stochastic Oscillator
- OTLK 10.94
- FAT 36.80
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About FAT FAT Brands Inc.
FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.